Raymond James & Associates’s Standex International SXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.62M Buy
47,138
+11,516
+32% +$2M 0.01% 1310
2024
Q2
$5.74M Buy
35,622
+1,764
+5% +$298K ﹤0.01% 1486
2024
Q1
$6.17M Buy
33,858
+21,197
+167% +$3.42M ﹤0.01% 1440
2023
Q4
$2.01M Buy
12,661
+301
+2% +$43.3K ﹤0.01% 2097
2023
Q3
$1.8M Buy
12,360
+478
+4% +$71.2K ﹤0.01% 2083
2023
Q2
$1.68M Buy
11,882
+1,735
+17% +$229K ﹤0.01% 2171
2023
Q1
$1.24M Buy
10,147
+802
+9% +$91.3K ﹤0.01% 2325
2022
Q4
$957K Buy
9,345
+1,676
+22% +$164K ﹤0.01% 2452
2022
Q3
$626K Buy
7,669
+609
+9% +$54.4K ﹤0.01% 2699
2022
Q2
$599K Buy
7,060
+1,003
+17% +$93.9K ﹤0.01% 2799
2022
Q1
$605K Buy
6,057
+1,043
+21% +$109K ﹤0.01% 2950
2021
Q4
$555K Buy
5,014
+873
+21% +$94.8K ﹤0.01% 3010
2021
Q3
$410K Buy
4,141
+831
+25% +$79K ﹤0.01% 3207
2021
Q2
$314K Buy
+3,310
New +$321K ﹤0.01% 3410

Other funds holding SXI

Raymond James & Associates's SXI Position: Q3 2024 in Review

Raymond James & Associates increased its Standex International (SXI) stake by 32% in Q3 2024, buying an estimated $2M and bringing the position to 47,138 shares worth $8.62M. The position accounts for 0.01% of the portfolio, ranked #1310.

Raymond James & Associates first reported a position in SXI in Q2 2021 and has held it in 14 quarters since. 234 funds tracked by Wall St. Rank hold SXI as of Q3 2024.

  • Raymond James & Associates held 47,138 shares of Standex International worth $8.62M as of Q3 2024.
  • Raymond James & Associates bought 11,516 Standex International shares in Q3 2024, an estimated $2M.
  • Standex International made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1310 holding.
  • Raymond James & Associates first reported a position in Standex International in Q2 2021 and has held it in 14 quarters since.
  • 234 funds tracked by Wall St. Rank held Standex International as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.